AI Article Synopsis
- The study examines how dietary phytoestrogens, particularly soy isoflavones, affect clinical outcomes for women undergoing infertility treatments using assisted reproductive technology (ART).
- It involved 315 women who participated in 520 ART cycles at a fertility center between 2007 and 2013, and measured outcomes such as implantation, clinical pregnancy, and live birth rates.
- Results showed that higher intake of soy isoflavones was linked to increased live birth rates, suggesting that dietary soy could enhance the success of ART treatments.
Article Abstract
Objective: To study the relation of dietary phytoestrogens intake and clinical outcomes of women undergoing infertility treatment with the use of assisted reproductive technology (ART).
Design: Prospective cohort study.
Setting: Fertility center.
Patient(s): A total of 315 women who collectively underwent 520 ART cycles from 2007 to 2013.
Intervention(s): None.
Main Outcome Measure(s): Implantation, clinical pregnancy, and live birth rates per initiated cycle.
Result(s): Soy isoflavones intake was positively related to live birth rates in ART. Compared with women who did not consume soy isoflavones, the multivariable-adjusted odds ratios of live birth (95% confidence interval) for women in increasing categories of soy isoflavones intake were 1.32 (0.76-2.27) for women consuming 0.54-2.63 mg/d, 1.87 (1.12-3.14) for women consuming 2.64-7.55 mg/d, and 1.77 (1.03-3.03) for women consuming 7.56-27.89 mg/d.
Conclusion(s): Dietary soy intake was positively related to the probability of having a live birth during infertility treatment with ART.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346414 | PMC |
| http://dx.doi.org/10.1016/j.fertnstert.2014.12.104 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!